Company Filing History:
Years Active: 2025
Title: Thomas Bjørnskov Poulsen: Innovator in Cancer Treatment
Introduction
Thomas Bjørnskov Poulsen is a notable inventor based in Højbjerg, Denmark. He has made significant contributions to the field of cancer treatment through his innovative research and development of macrocyclic compounds.
Latest Patents
Thomas holds a patent for "Macrocycles comprising a 4-amido-2,4-pentadienoate moiety for the treatment of hypoxic cancers." This patent describes macrocyclic compounds that include a 4-amido-2,4-pentadienoate (APD) moiety. The compounds are designed to exhibit toxicity that is selective to the hypoxic micro-environments often found in cancerous tissues. Therefore, these compounds are suitable for the treatment of hypoxic cancer cells. He has 1 patent to his name.
Career Highlights
Thomas is affiliated with Aarhus Universitet, where he continues to advance his research in cancer therapies. His work focuses on developing innovative solutions that target specific cancer cell environments, which is crucial for improving treatment efficacy.
Collaborations
Some of his notable coworkers include Per Hjerrild and Kristian Mark Jacobsen. Their collaborative efforts contribute to the ongoing research and development in the field of cancer treatment.
Conclusion
Thomas Bjørnskov Poulsen is a dedicated inventor whose work in developing targeted cancer therapies showcases the potential of innovative research in medicine. His contributions are paving the way for more effective treatments for hypoxic cancers.